Category: Pediatric cutaneous mucosal lymph node syndrome

Early application of intravenous immunoglobulin may reduce the probability of coronary artery disease in patients with Kawasaki disease. However, as immunoglobulin is a blood product, many parents are concerned about…

As the exact cause of Kawasaki disease is not known, there is no vaccine or other effective means of prevention associated with the disease.

The vast majority of children with Kawasaki disease make a full recovery after treatment and it does not affect the quality of life of the child. In the long term,…